Evidence map›Paper›PMID 40463087›Full record

ArticlebioRxiv : the preprint server for biology2025

Bile acids target an exposed cavity in the glucocorticoid receptor modulating receptor self-assembly, chromatin binding and transcriptional activity.

Alba Jiménez-Panizo, Thomas A Johnson, Kaustubh Wagh, Andrea Alegre-Martí, Inés Montoya Novoa, Agustina L Lafuente, Ulrich Eckhard, Luis Ángel Rodríguez-Lumbreras, Le Hoang, Martín Stortz and 11 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Alba Jiménez-PanizoDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.ORCID 0000-0001-7046-6162
Thomas A JohnsonNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.ORCID 0000-0002-9135-3252
Kaustubh WaghNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.ORCID 0000-0001-8514-027X
Andrea Alegre-MartíDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.ORCID 0000-0001-6646-8798
Inés Montoya NovoaDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.
Agustina L LafuenteIFIBYNE, UBA-CONICET, Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Buenos Aires, C1428EGA, Argentina.ORCID 0009-0004-8862-6880
Ulrich EckhardDepartment of Structural and Molecular Biology, Molecular Biology Institute of Barcelona (IBMB-CSIC), 08028 Barcelona, Spain.
Luis Ángel Rodríguez-LumbrerasInstituto de Ciencias de la Vid y del Vino (ICVV), CSIC - Universidad de La Rioja - Gobierno de La Rioja, 26007 Logroño, Spain.
Le HoangNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Martín StortzNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Montserrat AbellaDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.
Ido GoldsteinInstitute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, POB 12, Rehovot 7610001, Israel.ORCID 0000-0003-0139-1499
Annabel Valledor-FernándezDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.
Lyuba VarticovskiNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Irwin AriasOffice of the Director, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Diego M PresmanIFIBYNE, UBA-CONICET, Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Buenos Aires, C1428EGA, Argentina.ORCID 0000-0003-4515-8058
Diana A StavrevaNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.ORCID 0000-0002-7904-6452
Juan Fernández-RecioInstituto de Ciencias de la Vid y del Vino (ICVV), CSIC - Universidad de La Rioja - Gobierno de La Rioja, 26007 Logroño, Spain.
Pablo Fuentes-PriorDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.ORCID 0000-0002-6618-3204
Gordon L HagerNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.ORCID 0000-0002-9300-5331
Eva Estébanez-PerpiñáDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB). Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona (UB), 08028 Barcelona, Spain.ORCID 0000-0003-2687-5801

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glucocorticoid receptor (GR) is an essential transcription factor that controls metabolism and homeostasis. Glucocorticoids (GCs) activate the GR upon occupying the internal ligand-binding pocket (LBP) of its ligand-binding domain (GR-LBD), which has been the focus of most previous structure-function studies. Synthetic GCs such as dexamethasone are widely used to treat inflammatory diseases, but their chronic use results in major side effects, whose molecular underpinnings remain unresolved. Here we present a thorough analysis of the topography of GR-LBD and its ability to bind small-molecule compounds, especially cholesterol derivatives. We show that one important class of steroids, bile acids, bind to previously unidentified and highly conserved, surface-exposed cavities on GR-LBD. We show that bile acids affect GR turnover and self-assembly in living cells, modulating receptor transcriptional activity. These findings reveal a previously unrecognized mechanism of GR regulation, with implications for the design of GCs with novel mechanisms of action.

Indexed as

allosterybile acidsfluorescence microscopyglucocorticoid receptorligand-binding domainnuclear receptorsoligomerizationprotein degradationsmall molecule bindingtranscriptional regulation

Identifiers

PMID40463087
PMCPMC12132435

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.